Učitavanje...

Treatment with budesonide/formoterol pressurized metered-dose inhaler in patients with asthma: a focus on patient-reported outcomes

In the United States, budesonide/formoterol pressurized metered-dose inhaler (pMDI) is approved for treatment of asthma in patients aged ≥12 years whose asthma is not adequately controlled with an inhaled corticosteroid (ICS) or whose disease severity clearly warrants treatment with an ICS and a lon...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autor: O’Connor, Richard D
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2011
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3417922/
https://ncbi.nlm.nih.gov/pubmed/22915968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PROM.S16159
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!